Literature DB >> 22570473

Opposing roles for TRAF1 in the alternative versus classical NF-κB pathway in T cells.

Ann J McPherson1, Laura M Snell, Tak W Mak, Tania H Watts.   

Abstract

T cells lacking TRAF1 hyperproliferate in response to T cell receptor signaling but have impaired signaling downstream of specific TNFR family members such as 4-1BB. Here we resolve this paradox by showing that while TRAF1 is required for maximal activation of the classical NF-κB pathway downstream of 4-1BB in primary T cells, TRAF1 also restricts the constitutive activation of NIK in anti-CD3-activated T cells. Activation of the alternative NF-κB pathway is restricted in unstimulated cells by a cIAP1/2:TRAF2:TRAF3:NIK complex. Using knockdown of NIK by siRNA we show that in activated CD8 T cells TRAF1 is also involved in this process and that constitutive activation of the alternative NF-κB pathway is responsible for costimulation independent hyperproliferation and excess cytokine production in TRAF1-deficient CD8 T cells compared with WT CD8 T cells. The T cell costimulatory molecule 4-1BB critically regulates the survival of activated and memory CD8 T cells. We demonstrate that stimulation through 4-1BB induces cIAP1-dependent TRAF3 degradation and activation of the alternative NF-κB pathway. We also show that while both TRAF1 and cIAP1 have non-redundant roles in suppressing the alternative NF-κB pathway in T cells activated in the absence of costimulation, activation of the classical NF-κB pathway downstream of 4-1BB requires TRAF1, whereas cIAP1 plays a redundant role with cIAP2. Collectively these results demonstrate that TRAF1 plays a critical role in regulating T cell activation both through restricting the costimulation independent activation of NIK in activated T cells and by promoting the 4-1BB-induced classical NF-κB pathway.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22570473      PMCID: PMC3391120          DOI: 10.1074/jbc.M112.350538

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  64 in total

Review 1.  The B7-CD28 superfamily.

Authors:  Arlene H Sharpe; Gordon J Freeman
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

Review 2.  LMP1 structure and signal transduction.

Authors:  A G Eliopoulos; L S Young
Journal:  Semin Cancer Biol       Date:  2001-12       Impact factor: 15.707

3.  ERK-dependent Bim modulation downstream of the 4-1BB-TRAF1 signaling axis is a critical mediator of CD8 T cell survival in vivo.

Authors:  Laurent Sabbagh; Gayle Pulle; Yuanqing Liu; Erdyni N Tsitsikov; Tania H Watts
Journal:  J Immunol       Date:  2008-06-15       Impact factor: 5.422

4.  TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies.

Authors:  J M Zapata; M Krajewska; S Krajewski; S Kitada; K Welsh; A Monks; N McCloskey; J Gordon; T J Kipps; R D Gascoyne; A Shabaik; J C Reed
Journal:  J Immunol       Date:  2000-11-01       Impact factor: 5.422

5.  TRAF1 is a negative regulator of TNF signaling. enhanced TNF signaling in TRAF1-deficient mice.

Authors:  E N Tsitsikov; D Laouini; I F Dunn; T Y Sannikova; L Davidson; F W Alt; R S Geha
Journal:  Immunity       Date:  2001-10       Impact factor: 31.745

6.  Role of TNF receptor-associated factor 2 and p38 mitogen-activated protein kinase activation during 4-1BB-dependent immune response.

Authors:  J L Cannons; Y Choi; T H Watts
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

7.  Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-kappaB signaling.

Authors:  Sivakumar Vallabhapurapu; Atsushi Matsuzawa; Weizhou Zhang; Ping-Hui Tseng; Jonathan J Keats; Haopeng Wang; Dario A A Vignali; P Leif Bergsagel; Michael Karin
Journal:  Nat Immunol       Date:  2008-11-09       Impact factor: 25.606

8.  Control of canonical NF-kappaB activation through the NIK-IKK complex pathway.

Authors:  Brian Zarnegar; Soh Yamazaki; Jeannie Q He; Genhong Cheng
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-21       Impact factor: 11.205

9.  Both cIAP1 and cIAP2 regulate TNFalpha-mediated NF-kappaB activation.

Authors:  D J Mahoney; H H Cheung; R Lejmi Mrad; S Plenchette; C Simard; E Enwere; V Arora; T W Mak; E C Lacasse; J Waring; R G Korneluk
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-12       Impact factor: 11.205

10.  TRAF2 and TRAF3 signal adapters act cooperatively to control the maturation and survival signals delivered to B cells by the BAFF receptor.

Authors:  Sandra Gardam; Frederic Sierro; Antony Basten; Fabienne Mackay; Robert Brink
Journal:  Immunity       Date:  2008-02-28       Impact factor: 31.745

View more
  43 in total

1.  The signaling adaptor TRAF1 negatively regulates Toll-like receptor signaling and this underlies its role in rheumatic disease.

Authors:  Ali A Abdul-Sater; Maria I Edilova; Derek L Clouthier; Achire Mbanwi; Elisabeth Kremmer; Tania H Watts
Journal:  Nat Immunol       Date:  2016-11-28       Impact factor: 25.606

2.  4-1BB enhancement of CAR T function requires NF-κB and TRAFs.

Authors:  Gongbo Li; Justin C Boucher; Hiroshi Kotani; Kyungho Park; Yongliang Zhang; Bishwas Shrestha; Xuefeng Wang; Lawrence Guan; Nolan Beatty; Daniel Abate-Daga; Marco L Davila
Journal:  JCI Insight       Date:  2018-09-20

Review 3.  Regulation of NF-κB by TNF family cytokines.

Authors:  Matthew S Hayden; Sankar Ghosh
Journal:  Semin Immunol       Date:  2014-06-21       Impact factor: 11.130

4.  NF-κB and Rheumatoid Arthritis: Will Understanding Genetic Risk Lead to a Therapeutic Reward?

Authors:  Robert Scheinman
Journal:  For Immunopathol Dis Therap       Date:  2013-04-01

5.  Aging Converts Innate B1a Cells into Potent CD8+ T Cell Inducers.

Authors:  Catalina Lee-Chang; Monica Bodogai; Kanako Moritoh; Xin Chen; Robert Wersto; Ranjan Sen; Howard A Young; Michael Croft; Luigi Ferrucci; Arya Biragyn
Journal:  J Immunol       Date:  2016-03-16       Impact factor: 5.422

6.  Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4-1BB).

Authors:  Arantza Azpilikueta; Elixabet Bolaños; Valerie Lang; Sara Labiano; Maria A Aznar; Iñaki Etxeberria; Alvaro Teijeira; Maria E Rodriguez-Ruiz; Jose L Perez-Gracia; Maria Jure-Kunkel; Juan M Zapata; Manuel S Rodriguez; Ignacio Melero
Journal:  Oncoimmunology       Date:  2017-09-21       Impact factor: 8.110

Review 7.  TRAF family molecules in T cells: Multiple receptors and functions.

Authors:  Tina Arkee; Gail A Bishop
Journal:  J Leukoc Biol       Date:  2019-11-21       Impact factor: 4.962

8.  Effect of IL-7 Therapy on Phospho-Ribosomal Protein S6 and TRAF1 Expression in HIV-Specific CD8 T Cells in Patients Receiving Antiretroviral Therapy.

Authors:  Chao Wang; Maria I Edilova; Lisa E Wagar; Shariq Mujib; Meromit Singer; Nicole F Bernard; Thérèse Croughs; Michael M Lederman; Irini Sereti; Margaret A Fischl; Elisabeth Kremmer; Mario Ostrowski; Jean-Pierre Routy; Tania H Watts
Journal:  J Immunol       Date:  2017-12-08       Impact factor: 5.422

9.  A cell-intrinsic requirement for NF-κB-inducing kinase in CD4 and CD8 T cell memory.

Authors:  Alexander M Rowe; Susan E Murray; Hans-Peter Raué; Yoshinobu Koguchi; Mark K Slifka; David C Parker
Journal:  J Immunol       Date:  2013-09-04       Impact factor: 5.422

Review 10.  Roles for TNF-receptor associated factor 3 (TRAF3) in lymphocyte functions.

Authors:  Zuoan Yi; Wai Wai Lin; Laura L Stunz; Gail A Bishop
Journal:  Cytokine Growth Factor Rev       Date:  2013-12-25       Impact factor: 7.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.